Company intelligence / Profile preview

Theratome Bio

Indianapolis* / Florida*, Indiana / Florida*, United Statestheratomebio.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Theratome Bio has developed a proprietary secretome-based therapeutic platform derived from adult stem cells. Its lead product, Thera‑101, is an injectable biologic targeting ischemic brain injury with first-in-human trials underway. The company’s technology also aims to double the shelf life of transplanted organs and address dry eye disease. Preclinical data support tissue-protective and regenerative effects across multiple indications.[1][4]

Therapeutic areas
PulmonologyNephrologyOphthalmologyOtherNeurology
Modalities
Cell-free biologics (secretome-based therapeutics derived from adult stem cells)[1][2][6]Regenerative medicine products (secretomes/exosomes/proteins/micro-RNAs/metabolites)[6]
Industry
Biotech
02

Drug pipeline

3 assets

THERA-101

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

No major pharmaceutical partnerships disclosed as of May 2025.Spring Mill Venture Partners listed as an investor.[3]

Beyond the preview

Go deeper on Theratome Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theratome Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call